The role of endomyocardial biopsy in the diagnosis of cardiomyopathies

Italian Heart Journal

Volumn 3, Issue 6, 2002, Pages 348-353

  Frustaci, Andrea ^a   Pieroni, Maurizio ^a   Chimenti, Cristina ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Cardiomyopathies; Endomyocardial biopsy; Ischemic heart disease; Myocarditis

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM EXAMINATION; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART ATRIUM; HEART DILATATION; HEART MUSCLE BIOPSY; HEART VENTRICLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; MOLECULAR BIOLOGY; MYOCARDITIS; RESTRICTIVE CARDIOMYOPATHY; BIOPSY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; PATHOLOGY; REVIEW;

ARRHYTHMIA; BIOPSY; HUMAN; MYOCARDIAL DISEASES; MYOCARDIAL ISCHEMIA; MYOCARDIUM; CARDIOMYOPATHIES; HUMANS;

EID: 0035989029     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Symposium on biopsy in the field of internal medicine. (7) Endomyocardial biopsy
2. Diagnosis and classification of primary myocardial disease with the aid of endomyocardial biopsy
3. Left-ventricular endomyocardial biopsy
4. Results of biventricular endomyocardial biopsy in survivors of cardiac arrest with apparently normal hearts
5. Biopsy evidence of atrial myocarditis in an athlete developing transient sinoatrial disease
6. Histological substrate of atrial biopsies in patients with lone atrial fibrillation
7. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction
8. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
9. Myocardial cell death in human diabetes
10. Cell death in acromegalic cardiomyopathy
11. Evidence that human cardiac myocytes divide after myocardial infarction
12. Acute myocarditis. Rapid diagnosis by PCR in children
13. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis
14. Association of viral genome with graft loss in children after cardiac transplantation
15. Inflammatory left ventricular microaneurysms as a cause of appparently idiopathic ventricular tachyarrhythmias
16. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy
17. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy
18. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy
19. Safety and efficacy of recombinant human alpha-galactosidase A - Replacement therapy in Fabry's disease
20. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy
21. Enzyme-replacement therapy in mucopolysaccharidosis I
22. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis
23. Myocarditis. A histopathologic definition and classification
24. Morphometry and GH/IGF-1 axis deficiency may identify a form of dilated cardiomyopathy which is corrected by recombinant human growth hormone (rHGH)
25. Reversible dilated cardiomyopathy due to growth hormone deficiency
26. Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study
27. Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression
28. Idiopathic giant-cell myocarditis - Natural history and treatment
29. Giant cell myocarditis responding to immunosuppressive therapy
30. Acute myocarditis and left ventricular aneurysm as presentation of systemic lupus erythematosus
31. Advances in the understanding of myocarditis
32. Interferon-β treatment of patients with enteroviral and adenoviral cardiomyopathy causes effective virus clearance and long-term clinical improvement
33. Immunosuppressive and immunomodulatory treatment for myocarditis
34. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID)
35. Active lymphocytic myocarditis: Virologic and immunologic profile of responders vs non-responders to immunosuppressive therapy
36. Celiac disease associated with autoimmune myocarditis
37. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy
38. Specific heart muscle disease associated with glycogen storage disease type III: Clinical similarity to the dilated phase of hypertrophic cardiomyopathy
39. Hypertrophic cardiomyopathy in mucopoly-saccharidose: Regression after bone marrow transplantation
40. Cardiac variant of Fabry's disease mimicking a hypertrophic cardiomyopathy
41. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A
42. An atypical variant of Fabry's disease with manifestations confined to the myocardium
43. An atypical variant of Fabry's disease in men with left ventricular hypertrophy
44. Concealed myocardial storage disease (Fabry's disease): Pitfalls in the diagnosis of hypertrophic non obstructive cardiomyopathy
45. Prevalence of Anderson-Fabry disease in male patients with late onset hypetrophic cardiomyopathy
46. Late-onset primary LVH HCM versus cardiac Fabry variant
47. Enzyme-replacement therapy for Anderson-Fabry disease
48. Granulomatous myocarditis. Diagnosis by endomyocardial biopsy and response to corticosteroids in two patients
49. Restrictive cardiomyopathy
50. Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy
51. Persisting hypereosinophilia and myocardial activity in the fibrotic stage of endomyocardial disease
52. A novel variant of transthyretin, 59thr to lys, associated with autosomal dominant cardiac amyloidosis in an Italian family
53. Idiopathic myocardial vasculitis presenting as restrictive cardiomyopathy
54. Necrotizing myocardial vasculitis in Churg-Strauss syndrome: Clinico-histologic evaluation of steroids and immunosuppressive therapy
55. Ventricular preexcitation in children and young adults: Atrial myocarditis as a possible trigger of sudden death
56. Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmias
57. Sudden cardiac death in young people with apparently normal heart
58. Altered patterns of gene expression in response to myocardial infarction
59. Global bi-ventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis
60. Myocarditis mimicking acute myocardial infarction: Role of endomyocardial biopsy in the differential diagnosis
61. Cardiovascular complications of cocaine use
62. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury
63. Heart failure and apoptosis: Electrophoretic methods support data from micro- and macro-arrays. A critical review of genomics and proteomics
64. Low-density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy
65. Effects of early angiotensin- converting enzyme inhibition on cardiac gene expression after acute myocardial infarction
66. Host gene regulation during coxsackievirus B3 infection in mice: Assessment by microarrays
67. Mobilized bone marrow cells repair the infarcted heart, improving function and survival
68. Myocyte renewal and ventricular remodelling